Long-term effect of rituximab in anti-mag polyneuropathy

Neurology

Volumn 71, Issue 21, 2008, Pages 1742-1744

  Benedetti, L ^a   Briani, C ^b   Franciotta, D ^c   Carpo, M ^d   Padua, L ^e   Zara, G ^b   Zambello, R ^b   Sormani, M P ^a   Mancardi, G L ^a   Nobile Orazio, E ^f   Schenone, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d IRCCS   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; MYELIN ASSOCIATED GLYCOPROTEIN; RITUXIMAB; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HUMAN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; POLYNEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHORT FORM 36; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; IMMUNOLOGY; MIDDLE AGED; TIME;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MYELIN-ASSOCIATED GLYCOPROTEIN; POLYNEUROPATHIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149262036     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000335268.70325.33     Document Type: Article

References (7)

1. Renaud S, Gregor M, Fuhr P, et al. Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 2003;27:611-615.
2. Dalakas MC, Rakocevic G, Salajegheh K, Dambrosia J, Raju R, McElroy B. A double-blind, placebo-controlled study of rituximab in patients with anti-MAG antibody-demyelinating polyneuropathy. Ann Neurol 2006; 60(Suppl 3):S91.
3. Benedetti L, Briani C, Grandis M, et al. Predictors of response to Rituximab in patients with neuropathy and anti-MAG IgM. J Periph Nerv Syst 2007;12:102-107.
4. Renaud S, Fuhr P, Gregor M, et al. High-dose rituximab and anti-MAG associated polyneuropathy. Neurology 2006;66:742-744.
5. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998;51:1025-1036.
6. Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, et al. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long term follow-up analysis. Ann Hematol 2007;86:871-877.
7. Cianchini G, Masini C, Lupi F, Corona R, De Pità O, Puddu P. Severe persistent pemphigoid gestationis: longterm remission with rituximab. Br J Dermatol 2007;157: 388-389.